Shujun Liang

1 article listing Shujun Liang in Nature Communications, indexed by Paperzzz from Crossref and OSF.

1. Camrelizumab plus chemotherapy versus chemoradiotherapy as neoadjuvant therapy for resectable esophageal squamous cell carcinoma: Phase 2 randomized trial (REVO) Nature Communications